Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Prognostic Significance of Fc Receptor-Like 1 in Patients With Chronic Lymphocytic Leukemia, Hairy Cell Leukemia, and Various B-Cell Non-Hodgkin's Lymphoma Publisher



Yousefi Z1 ; Eskandari N1, 2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Immunology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Applied Physiology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Leukemia Research Reports Published:2019


Abstract

Fc receptor-like 1 (FCRL1) positively regulates B-cell responses and may involve in the pathogenesis of B-cell malignancies. This study examined the expression pattern of FCRL1 in B-cell non-Hodgkin's lymphoma patients using real-time PCR and flow cytometry. The results revealed higher levels of FCRL1 expression in diffuse large B-cell lymphoma, hairy cell leukemia, and Burkitt lymphoma patients compared with control groups. There was a significant reduction in the levels of FCRL1 expression in chronic lymphocytic leukemia and mantle cell lymphoma patients compared with healthy individuals. These findings suggest FCRL1 as an excellent marker for the prognosis or immunotherapy of B-cell malignancies. © 2019
Related Docs
View other Related Docs
1. Fc Receptor-Like 1 As a Promising Target for Immunotherapeutic Interventions of B-Cell-Related Disorders, Biomarker Insights (2019)
2. Fc Receptor-Like 1 (Fcrl1) Is a Novel Biomarker for Prognosis and a Possible Therapeutic Target in Diffuse Large B-Cell Lymphoma, Molecular Biology Reports (2023)
3. Evaluation of Arg Protein Expression in Mature B Cell Lymphomas Compared to Non-Neoplastic Reactive Lymph Node, Cellular Immunology (2009)
4. Prognostic Significance of Aberrant Cd5 Expression in B-Cell Leukemia, Oncology Reviews (2019)
5. Bcl-2 Associated Athanogene-1 Overexpression in Diffuse Large B-Cell Lymphoma, Iranian Journal of Immunology (2008)
6. Research Paper: Immune Checkpoint Molecules in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System, Basic and Clinical Neuroscience (2020)
7. Measurement of Pyruvate Dehydrogenase Enzyme in Patients With Diffuse Large B-Cell Lymphoma Relapse, Tehran University Medical Journal (2020)
8. Livin, a Novel Marker in Lymphoma Type Distinction, Annals of Diagnostic Pathology (2014)
Experts (# of related papers)
View all Related Experts
Nahid Eskandari (2)
Majid Ghanavat (1)
Other Related Docs
9. The Effect of Epstein-Barr Virus Latent Membrane Protein-1 Status on Outcome of Patients With Classic Hodgkin's Lymphoma, Pakistan Journal of Medical Sciences (2008)
10. A Systematic Review Evaluating the Efficacy of Autologous Hematopoietic Transplantation for Diffuse Large B Cell Lymphoma-Type Richter Syndrome, Caspian Journal of Internal Medicine (2023)